Given that head and neck squamous cell carcinoma is often characterized by aberrant activation of YAP/TAZ, NDR1/2 kinases may also have significant regulatory roles in this tumor type, where their dysregulation could disrupt Hippo signaling and thereby promote tumor cell proliferation, invasion, and drug resistance. The gene discussed is WWTR1; the disease is head and neck squamous cell carcinoma.